Want to create an interactive transcript for this episode?
Podcast: Dr. Chapa’s OBGYN Clinical Pearls
Episode: NIPT’s Sex Chromosome Abnormalities: Clinical Pearls.
Description: NIPT is a prenatal SCREENING method that involves analysis of cell-free fetal DNA (cfDNA) in maternal blood. Prenatal screening for sex chromosome aneuploidies (SCAs) has become readily available through expanded non-invasive prenatal testing (NIPT). NIPTs became commercially available in 2011 and has since been introduced in more than 60 countries around the world and is now part of mainstream obstetrical practice. Initially
offered as a secondary screen for pregnancies with a high probability of a fetal chromosomal anomaly, NIPT is now often offered and recommended as a first-line
screening test for the main chromosomal aneuploidies. Initially, NIPT was available to screen for...